Previously submitted to: JMIR Research Protocols (no longer under consideration since May 22, 2025)
Date Submitted: Apr 11, 2024
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Efficacy and safety of zhenqifuzheng granule for gastric cancer: A protocol for systematic review and meta-analysis
ABSTRACT
Background:
The incidence and mortality of gastric cancer are very high. Clinical comprehensive treatment needs more drug participation. Zhenqi Fuzheng granule has been widely used in the treatment of gastric cancer as an adjunct. Clinical practice shows that Zhenqi Fuzheng granule has certain therapeutic advantages. However, the exact efficacy and safety of Zhenqi Fuzheng granules have not been systematically studied.
Objective:
This study aims to summarize the efficacy and safety of Zhenqi Fuzheng in the treatment of gastric cancer through meta-analysis.
Methods:
The protocol followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. Relevant randomized controlled trials were searched from PubMed, the Cochrane Library, Embase, the China National Knowledge Infrastructure, Wanfang Database, Chinese Science and echnology Periodical Database, and Chinese Biomedical Literature Database.Papers in English or Chinese published from their inception to August 2021 will be included without any restrictions. Cochrane Risk of Bias tool will be used to assess the risk of bias of included studies. The RevMan 5.4 and Stata 16.0 software will be applied for statistical analyses. Statistical heterogeneity will be computed by I2 tests. Sensitivity analysis will be conducted to evaluate the stability of the results. The publication bias will be evaluated by funnel plots and Egger’s test. The quality of evidence will be assessed by the GRADE system.
Results:
The results of our research will be published in a peer-reviewed journal.
Conclusions:
The conclusion of this study will provide helpful evidence of the effect and safety of Zhenqi Fuzheng granule for the treatment of GC in clinical practice.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.